144 related articles for article (PubMed ID: 16914135)
1. Suppression by bepotastine besilate of substance P-induced itch-associated responses through the inhibition of the leukotriene B4 action in mice.
Andoh T; Kuraishi Y
Eur J Pharmacol; 2006 Oct; 547(1-3):59-64. PubMed ID: 16914135
[TBL] [Abstract][Full Text] [Related]
2. Oral administration of bepotastine besilate suppressed scratching behavior of atopic dermatitis model NC/Nga mice.
Tanizaki H; Kambe N; Nakamura Y; Tanaka A; Matsuda H; Miyachi Y
Int Arch Allergy Immunol; 2008; 145(4):277-82. PubMed ID: 18004068
[TBL] [Abstract][Full Text] [Related]
3. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H
Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of azelastine on substance P-induced itch-associated response in mice.
Andoh T; Kuraishi Y
Eur J Pharmacol; 2002 Feb; 436(3):235-9. PubMed ID: 11858803
[TBL] [Abstract][Full Text] [Related]
5. Involvement of blockade of leukotriene B(4) action in anti-pruritic effects of emedastine in mice.
Andoh T; Kuraishi Y
Eur J Pharmacol; 2000 Oct; 406(1):149-52. PubMed ID: 11011046
[TBL] [Abstract][Full Text] [Related]
6. Glycyrrhetinic acid prevents cutaneous scratching behavior in mice elicited by substance P or PAR-2 agonist.
Akasaka Y; Yoshida T; Tsukahara M; Hatta A; Inoue H
Eur J Pharmacol; 2011 Nov; 670(1):175-9. PubMed ID: 21925497
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene B(4) mediates sphingosylphosphorylcholine-induced itch-associated responses in mouse skin.
Andoh T; Saito A; Kuraishi Y
J Invest Dermatol; 2009 Dec; 129(12):2854-60. PubMed ID: 19657356
[TBL] [Abstract][Full Text] [Related]
8. 12(S)-HPETE induces itch-associated scratchings in mice.
Kim DK; Kim HJ; Sung KS; Kim H; Cho SA; Kim KM; Lee CH; Kim JJ
Eur J Pharmacol; 2007 Jan; 554(1):30-3. PubMed ID: 17112507
[TBL] [Abstract][Full Text] [Related]
9. Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice.
Ui H; Andoh T; Lee JB; Nojima H; Kuraishi Y
Eur J Pharmacol; 2006 Jan; 530(1-2):172-8. PubMed ID: 16359660
[TBL] [Abstract][Full Text] [Related]
10. How important are NK1 receptors for influencing microvascular inflammation and itch in the skin? Studies using Phoneutria nigriventer venom.
Costa SK; Starr A; Hyslop S; Gilmore D; Brain SD
Vascul Pharmacol; 2006 Oct; 45(4):209-14. PubMed ID: 16914387
[TBL] [Abstract][Full Text] [Related]
11. Bepotastine besilate for the treatment of pruritus.
Bielory L; Duttachoudhury S; McMunn A
Expert Opin Pharmacother; 2013 Dec; 14(18):2553-69. PubMed ID: 24191914
[TBL] [Abstract][Full Text] [Related]
12. Effect of P-glycoprotein on intestinal absorption and brain penetration of antiallergic agent bepotastine besilate.
Ohashi R; Kamikozawa Y; Sugiura M; Fukuda H; Yabuuchi H; Tamai I
Drug Metab Dispos; 2006 May; 34(5):793-9. PubMed ID: 16455807
[TBL] [Abstract][Full Text] [Related]
13. Bepotastine besilate ophthalmic solution for the relief of nonocular symptoms provoked by conjunctival allergen challenge.
Torkildsen GL; Williams JI; Gow JA; Gomes PJ; Abelson MB; McNamara TR;
Ann Allergy Asthma Immunol; 2010 Jul; 105(1):57-64. PubMed ID: 20642205
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide enhances substance P-induced itch-associated responses in mice.
Andoh T; Kuraishi Y
Br J Pharmacol; 2003 Jan; 138(1):202-8. PubMed ID: 12522091
[TBL] [Abstract][Full Text] [Related]
15. Non-clinical pharmacology, pharmacokinetics, and safety findings for the antihistamine bepotastine besilate.
Williams JI; Gow JA; Klier SM; McCue SL; Salapatek AM; McNamara TR
Curr Med Res Opin; 2010 Oct; 26(10):2329-38. PubMed ID: 20735291
[TBL] [Abstract][Full Text] [Related]
16. Intradermal leukotriene B4, but not prostaglandin E2, induces itch-associated responses in mice.
Andoh T; Kuraishi Y
Eur J Pharmacol; 1998 Jul; 353(1):93-6. PubMed ID: 9721045
[TBL] [Abstract][Full Text] [Related]
17. Role of leukotriene B4 in 5-lipoxygenase metabolite- and allergy-induced itch-associated responses in mice.
Tsuji F; Aono H; Tsuboi T; Murakami T; Enomoto H; Mizutani K; Inagaki N
Biol Pharm Bull; 2010; 33(6):1050-3. PubMed ID: 20522976
[TBL] [Abstract][Full Text] [Related]
18. Downmodulatory effects of the antihistaminic drug bepotastine on cytokine/chemokine production and CD54 expression in human keratinocytes.
Kobayashi M; Kabashima K; Nakamura M; Tokura Y
Skin Pharmacol Physiol; 2009; 22(1):45-8. PubMed ID: 19088500
[TBL] [Abstract][Full Text] [Related]
19. Substance P induction of itch-associated response mediated by cutaneous NK1 tachykinin receptors in mice.
Andoh T; Nagasawa T; Satoh M; Kuraishi Y
J Pharmacol Exp Ther; 1998 Sep; 286(3):1140-5. PubMed ID: 9732370
[TBL] [Abstract][Full Text] [Related]
20. Neuronal conditions of spinal cord in dermatitis are improved by olopatadine.
Hamada R; Seike M; Kamijima R; Ikeda M; Kodama H; Ohtsu H
Eur J Pharmacol; 2006 Oct; 547(1-3):45-51. PubMed ID: 16934247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
